연구동향 분석

Study of adjuvant effects on pandemic influenza H1N1 vaccine = 팬데믹 인플루엔자 H1N1 백신 면역보강제 효능 연구

NGUYEN THI QUYEN 2020년

논문상세정보
인용/피인용
' Study of adjuvant effects on pandemic influenza H1N1 vaccine = 팬데믹 인플루엔자 H1N1 백신 면역보강제 효능 연구' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • CTL activity
  • Influenza virus
  • adcc
  • cellular immune response
  • cross protection
  • humoral immune response
  • vaccine adjuvant
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
46 0

0.0%

' Study of adjuvant effects on pandemic influenza H1N1 vaccine = 팬데믹 인플루엔자 H1N1 백신 면역보강제 효능 연구' 의 참고문헌

  • structure and function of influenza virus ns1 and ns2 proteins ]
    55 : 2605-2609 . [1997]
  • how ) do aluminium adjuvants work ?
    102 : 10- 15 . [2006]
  • Weber MA , Tinoco JC , Mezerville MH , Faingezicht I , Kosuwon P , Lopez P , Borja-Tabora C , Li P
    L , Dubin
  • Virus-like particles containing multiple m2 extracellular domains confer improved cross-protection against various subtypes of influenza virus
    21 : 485-492 [2013]
  • Vesikari T, Kirstein J, Go GD, Leav B, Ruzycky ME, Isakov L, de Bruijn M, Oberye J, Heijnen E. 2018. Efficacy, immunogenicity, and safety evaluation of an mf59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: A multicentre, randomised controlled, observer-blinded, phase 3 trial. The Lancet Respiratory Medicine, 6: 345-356.
  • Vaccine adjuvants current status and prospects on controlled release adjuvancity
    19 : 197-206 . [2011]
  • Vaccine adjuvants : Understanding the structure and mechanism of adjuvanticity
    37 : 3167-3178 [2019]
  • Vaccine adjuvants : Putting innate immunity to work
    33 : 492-503 [2010]
  • Vaccine adjuvants : Mode of action
    0.3152777778 [2013]
  • Vaccine adjuvant mf59 promotes the intranodal differentiation of antigen-loaded and activated monocyte-derived dendritic cells
    12 [2017]
  • Update : Acip recommendations for the use of quadrivalent live attenuated influenza vaccine ( laiv4 ) united states , 2018-19 influenza season .
    67 : 643-645 . [2018]
  • Understanding dendritic cell and t-lymphocyte traffic through the analysis of chemokine receptor expression
    177 : 134-140 [2000]
  • Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, PantinJackwood MJ, Schultz-Cherry S, Solorzano A, Van Rooijen N, Katz JM, Basler CF. 2005. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: Functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol, 79: 14933-14944.
  • Trivalent and quadrivalent mf59® -adjuvanted influenza vaccine in young children : A dose-and schedule-finding study
    29 : 8696-8704 . [2011]
  • Treatment of influenza virus-infected scid mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection
    254 : 138- 146 . [1999]
  • Traditional and new influenza vaccines
    26 : 476-492 [2013]
  • Towards an understanding of the adjuvant action of aluminium
    9 : 287-293 . [2009]
  • Toll-like receptors and innate immunity
    388 : 621-625 [2009]
  • Toll-like receptor ligand-based vaccine adjuvants require intact myd88 signaling in antigen-presenting cells for germinal center formation and antibody production
    0.4895833333 [2017]
  • Toll-like receptor control of the adaptive immune responses
    5 : 987-995 [2004]
  • Toll-like receptor 4 in acute viral infection : Too much of a good thing .
    14 : e1007390 . [2018]
  • Tlr-based immune adjuvants
    29 : 3341-3355 . [2011]
  • Therapeutic applications of synthetic cpg oligodeoxynucleotides as tlr9 agonists for immune modulation .
    21 : 387-401 . [2007]
  • The vaccine adjuvant monophosphoryl lipid a as a trif-biased agonist of tlr4
    316 : 1628-1632 . [2007]
  • The role of chemokines in the regulation of dendritic cell trafficking
    66 : 1-9 [1999]
  • The origins of pandemic influenza -lessons from the 1918 virus .
    353 : 2209-2211 . [2005]
  • The mechanisms of action of vaccines containing aluminum adjuvants : An in vitro vs in vivo paradigm
    0.2923611111 [2015]
  • The mechanism of action of mf59–an innately attractive adjuvant formulation
    30 : 4341-4348 [2012]
  • The induction of innate and adaptive immunity by biodegradable poly ( gamma-glutamic acid ) nanoparticles via a tlr4 and myd88 signaling pathway
    32 : 5206-5212 . [2011]
  • The emergence of pandemic influenza viruses
    1 : 9-13 . [2010]
  • The development of inducible bronchus-associated lymphoid tissue depends on il-17
    12 : 639-646 . [2011]
  • The dendritic cell lineage : Ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting
    31 : 563-604 . [2013]
  • The adjuvants aluminum hydroxide and mf59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells
    180 : 5402-5412
  • The adjuvanted influenza vaccines with novel adjuvants : Experience with the mf59-adjuvanted vaccine
    [2001]
  • The adjuvant mf59 : A 10year perspective
    [2000]
  • Tcr–like antibodies mediate complement and antibody-dependent cellular cytotoxicity against epstein-barr virus– transformed b lymphoblastoid cells expressing different hla-a * 02 microvariants
    7.182638889
  • Targeting the innate immune response with improved vaccine adjuvants
    11 : S63-68 [2005]
  • Targeting dendritic cells : A promising strategy to improve vaccine effectiveness
    5 : e66 [2016]
  • Systematic identification of type i and type ii interferon-induced antiviral factors
    109 : 4239-4244 [2012]
  • Synthetic toll-like receptor 4 ( tlr4 ) and tlr7 ligands work additively via myd88 to induce protective antiviral immunity in mice
    91 . [2017]
  • Swedish medical products agency publishes report from a case inventory study on pandemrix vaccination and development of narcolepsy with cataplexy
    16 [2011]
  • Structures of influenza a proteins and insights into antiviral drug targets
    17 : 530-538 . [2010]
  • Smalls-Mantey A, Doria-Rose N, Klein R, Patamawenu A, Migueles SA, Ko SY, Hallahan CW, Wong H, Liu B, You L, Scheid J, Kappes JC, Ochsenbauer C, Nabel GJ, Mascola JR, Connors M. 2012b. Antibody-dependent cellular cytotoxicity against primary hiv-infected cd4+ t cells is directly associated with the magnitude of surface igg binding. J Virol, 86: 8672- 8680.
  • Simulating the immune system
    2 : 69-77 . [2000]
  • Secretory and systemic immunological response inChildren infected with live attenuated influenza a virus vaccines
    36 : 1102-1108 . [1982]
  • Sambhara S, Kurichh A, Miranda R, Tumpey T, Rowe T, Renshaw M, Arpino R, Tamane A, Kandil A, James O, Underdown B, Klein M, Katz J, Burt D. 2001. Heterosubtypic immunity against human influenza a viruses, including recently emerged avian h5 and h9 viruses, induced by flu-iscom vaccine in mice requires both cytotoxic t-lymphocyte and macrophage function. Cell Immunol, 211: 143-153.
  • Safety of mf59-adjuvanted versus non-adjuvanted influenza vaccines inChildren and adolescents : An integrated analysis
    28 : 7331-7336 [2010]
  • Safety of as03-adjuvanted influenza vaccines : A review of the evidence
    37 : 3006-3021 . [2019]
  • Role of virion m2 protein in influenza virus uncoating : Specific reduction in the rate of membrane fusion between virus and liposomes by amantadine
    75 ( Pt 4 ) : 945-948 . [1994]
  • Risk of narcolepsy inChildren and young people receiving as03 adjuvanted pandemic a/h1n1 2009 influenza vaccine : Retrospective analysis
    346 : f794 . [2013]
  • Risk of narcolepsy after as03 adjuvanted pandemic a/h1n1 2009 influenza vaccine in adults : ACase-coverage study in england
    39 : 1051-1057 . [2016]
  • Respiratory syncytial virus-induced activation and migration of respiratory dendriticCells and subsequent antigen presentation in the lungdraining lymph node .
    83 : 7235-7243 . [2009]
  • Respiratory epithelialCells in innate immunity to influenza virus infection
    343 : 13-21 [2011]
  • Relative effectiveness ofCellcultured and egg-based influenza vaccines among elderly persons in the united states , 2017-2018
    220 : 1255-1264 [2019]
  • Recombinant vaccines and the development of new vaccine strategies
    45 : 1102-1111 [2012]
  • Recognition of viral hemagglutinins by nkp44 but not by nkp30 .
    31 : 2680-2689 . [2001]
  • Recognition of homoand heterosubtypic variants of influenza a viruses by humanCd8+ t lymphocytes
    172 : 2453-2460 . [2004]
  • Recognition of haemagglutinins on virus-infectedCells by nkp46 activates lysis by human nkCells
    409 : 1055-1060 . [2001]
  • Receptor binding by an h7n9 influenza virus from humans .
    [2013]
  • RecentClinical experience with vaccines using mpland qs-21-containing adjuvant systems
    10 : 471-486 . [2011]
  • Putting endotoxin to work for us : Monophosphoryl lipid a as a safe and effective vaccine adjuvant
    65 : 3231-3240 [2008]
  • Pulmonary immunity to viruses
    131 : 1737-1762 . [2017]
  • Public health and medical responses to the 1957-58 influenza pandemic
    7 : 265-273 . [2009]
  • ProinflammatoryCytokine responsesCorrespond with subjective side effects after influenza virus vaccination
    33 : 3360-3366 [2015]
  • Prevention andControl of seasonal influenza with vaccines : Recommendations of the advisoryCommittee on immunization practices—united states , 2019–20 influenza season
    68:01:00 [2019]
  • Prevention andControl of influenza with vaccines : Recommendations of the advisoryCommittee on immunization practices ( acip ) -united states , 2012-13 influenza season
    61 : 613-618 . [2012]
  • Preparation of γ-pga hydrogels and swelling behaviors in salt solutions with different ionic valence numbers
    7 : 11085-11093 . [2017]
  • Polyionic vaccine adjuvants : Another look at aluminum salts and polyelectrolytes
    4 : 23-45 [2015]
  • Poly-gamma-glutamic acidComplexed with alum inducesCross-protective immunity of pandemic h1n1 vaccine
    1.530555556 [2019]
  • Poly-gamma-glutamic acid/chitosan nanogel greatly enhances the efficacy and heterosubtypicCross-reactivity of h1n1 pandemic influenza vaccine
    7 : 44839 . [2017]
  • Passively acquired antibody-dependent cellular cytotoxicity ( adcc ) activity in hiv-infected infants is associated with reduced mortality .
    17 : 500-506 . [2015]
  • Partinen M. 2018a . Narcolepsy associated with pandemrix vaccine
    18:43
  • Palese P. 2008The biology of influenza viruses
    26 Suppl 4 : D49-53 .
  • Origins and evolutionary genomics of the 2009 swine-origin h1n1 influenza a epidemic
    [2009]
  • Oral administration of poly-gamma-glutamate induces tlr4- and dendritic cell-dependent antitumor effect .
    58 : 1781-1794 . [2009]
  • Oral administration of high molecular mass polygamma-glutamate induces nk cell-mediated antitumor immunity
    179 : 775-780 . [2007]
  • On the use of magnesium hydroxide towards halogen-free flame-retarded polyamide6/polypropylene blends
    97 : 1447-1457 . [2012]
  • Oil-in-water emulsion adjuvants for pediatric influenza vaccines : A systematic review and meta-analysis
    11 : 1-12 . [2020]
  • Oil-in-water emulsion adjuvant with influenza vaccine in young children
    365 : 1406-1416 . [2011]
  • Non-cytotoxic antiviral activities of granzymes in the context of the immune antiviral state
    235 : 128-146 [2010]
  • New hepatitis b vaccine formulated with an improved adjuvant system
    6 : 133-140 . [2007]
  • Neuraminidasemediated , nkp46-dependent immune-evasion mechanism of influenza viruses
    3 : 1044-1050 . [2013]
  • Natural killer cell mediated antibodydependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodies
    0.2194444444 [2013]
  • Natural and edible biopolymer poly-gamma-glutamic acid : Synthesis , production , and applications
    5 : 352-366 . [2005]
  • N. 2009 . As04 , an aluminum salt- and tlr4 agonistbased adjuvant system , induces a transient localized innate immune response leading to
    J Immunol , 183
  • Mutwiri G. 2013Mechanisms of action of adjuvants
    0.2458333333
  • Molecular changes associated with adaptation of human influenza a virus in embryonated chicken eggs
    350 : 137-145 [2006]
  • Mf59 : A safe and potent adjuvant for human use
    pp . 249- 263 [2017]
  • Metabolic engineering of escherichia coli to produce a monophosphoryl lipid a adjuvant
    57 : 193-202 . [2020]
  • Mechanisms of stimulation of the immune response by aluminum adjuvants
    20 Suppl 3 : S34-39 . [2002]
  • Mechanisms and consequences of dendritic cell migration
    29 : 325-342 . [2008]
  • Ma C. 2020Better influenza vaccines : An industry perspective
    27:33:00
  • Long-term immunogenicity of an inactivated split-virion 2009 pandemic influenza a h1n1 virus vaccine with or without aluminum adjuvant in mice
    22 : 327- 335 [2015]
  • Long-term and cross-reactive immunogenicity of inactivated trivalent influenza vaccine in the elderly : Mf59-adjuvanted vaccine versus unadjuvanted vaccine
    85 : 1591-1597 . [2013]
  • Live attenuated influenza vaccine in children induces b-cell responses in tonsils
    214 : 722-731 . [2016]
  • Linking innate to adaptive immunity through dendritic cells
    [2006]
  • Licensing the first reduced , 6microg dose whole virion , aluminum adjuvanted seasonal influenza vaccine - a randomized-controlled multicenter trial
    37 : 258-264 . [2019]
  • Li P. 2017b . Immunogenicity and safety of an as03-adjuvanted h7n1 vaccine in healthy adults : A phase i/ii , observer-blind , randomized , controlled trial
    35 : 1431-1439 .
  • Lessons from pandemic influenza a ( h1n1 ) : The research-based vaccine industry 's perspective
    29 : 1135-1138 . [2011]
  • Krewski D. 2016Reviewing the history of pandemic influenza : Understanding patterns of emergence and transmission
    5
  • Kinnear E. 2018Adjuvanted influenza vaccines
    14 : 550-564 .
  • Key roles of adjuvants in modern vaccines
    19 : 1597-1608 . [2013]
  • Iscom technology-based matrix m adjuvant : Success in future vaccines relies on formulation
    10 : 401-403 . [2011]
  • Intranasal administration of poly-gamma glutamate induced antiviral activity and protective immune responses against h1n1 influenza a virus infection
    0.6111111111 [2015]
  • Interleukin-12 profoundly upregulates the synthesis of antigen-specific complement-fixing igg2a , igg2b and igg3 antibody subclasses in vivo
    25 : 823-829 . [1995]
  • Interferon-lambda contributes to innate immunity of mice against influenza a virus but not against hepatotropic viruses
    4 : e1000151 [2008]
  • Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations
    6 : 31578 . [2016]
  • Innate immunity to influenza virus infection
    14 : 315-328 [2014]
  • Influenza-specific antibody-dependent cellular cytotoxicity : Toward a universal influenza vaccine .
    193 : 469-475 . [2014]
  • Influenza-induced lung trm : Not all memories last forever
    95 : 651-655 [2017]
  • Influenza virus serology -- a comparative study
    78 : 163-169 [1999]
  • Influenza virus neuraminidase : Structure and function
    1 : 26-32 . [2009]
  • Influenza virus matrix protein is the major driving force in virus budding
    74 : 11538-11547 [2000]
  • Influenza virus m2 protein has ion channel activity
    69 : 517-528 [1992]
  • Influenza virus assembly and budding
    411 : 229-236 [2011]
  • Influenza vaccination in children primed with mf59® -adjuvanted or non-adjuvanted seasonal influenza vaccine
    11 : 2102- 2112 [2015]
  • Influenza a virus lacking the ns1 gene replicates in interferon-deficient systems
    252 : 324-330 . [1998]
  • Influenza -- who cares
    0.4423611111 [2002]
  • Induction of heterosubtypic immunity to influenza virus by intranasal immunization
    82 : 1350-1359 . [2008]
  • Incidence of narcolepsy after h1n1 influenza and vaccinations : Systematic review and meta-analysis
    38 : 177-186 .
  • In vivo detection of dendritic cell antigen presentation to cd4 ( + ) t cells
    185 : 2133-2141 [1997]
  • Impact of the 2004-2005 influenza vaccine shortage on pediatric practice : A national survey
    123 : e186-192 . [2009]
  • Immunotherapeutic uses of cpg oligodeoxynucleotides .
    4 : 249-258 . [2004]
  • Immunotherapeutic applications of cpg oligodeoxynucleotide tlr9 agonists .
    61 : 195-204 . [2009]
  • Immunogenicity of trivalent influenza vaccines in patients with chronic kidney disease undergoing hemodialysis : Mf59-adjuvanted versus non-adjuvanted vaccines
    12 : 2902-2908 [2016]
  • Immunogenicity and safety of cellderived mf59® -adjuvanted a/h1n1 influenza vaccine for children
    11 : 358-376 . [2015]
  • Immunogenicity and safety of as03-adjuvanted 2009 influenza a h1n1 vaccine in children 6-35 months
    28 : 5837-5844 . [2010]
  • Immunogenicity and safety of an as03-adjuvanted h7n1 vaccine in adults 65 years of age and older : A phase ii , observerblind , randomized , controlled trial
    35 : 1865-1872 .
  • Immune responses to influenza virus infection
    [2011]
  • Immune responses to influenza virus and its correlation to age and inherited factors
    1.570138889 [2016]
  • Il-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease
    179 : 248-258 . [2011]
  • Identification of antigen and adjuvant doses resulting in optimal immunogenicity and antibody persistence up to 1 year after immunization with a pandemic a/h1n1 influenza vaccine in children 3 to < 9 years of age
    31 : e59-e65 . [2012]
  • Human influenza viruses and cd8 ( + ) t cell responses
    16 : 132- 142 [2016]
  • How nf-kappab is activated : The role of the ikappab kinase ( ikk ) complex
    18 : 6867-6874 . [1999]
  • Host immune response to influenza a virus infection
    0.5972222222 [2018]
  • Host adaptation and transmission of influenza a viruses in mammals
    3 : e9 . [2014]
  • Hoft DF, Babusis E, Worku S, Spencer CT, Lottenbach K, Truscott SM, Abate G, Sakala IG, Edwards KM, Creech CB, Gerber MA, Bernstein DI, Newman F, Graham I, Anderson EL, Belshe RB. 2011. Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse t-cell responses in young children. J Infect Dis, 204: 845-853.
  • H5n1 influenza vaccine formulated with as03 a induces strong cross-reactive and polyfunctional cd4 t-cell responses
    31 : 443-454 [2011]
  • Glaxosmithkline adjuvant systems in vaccines : Concepts , achievements and perspectives
    6 : 723-739 . [2007]
  • Gao Y, Zhang Y, Shinya K, Deng G, Jiang Y, Li Z, Guan Y, Tian G, Li Y, Shi J, Liu L, Zeng X, Bu Z, Xia X, Kawaoka Y, Chen H. 2009. Identification of amino acids in ha and pb2 critical for the transmission of h5n1 avian influenza viruses in a mammalian host. PLoS Pathog, 5: e1000709.
  • G. 2008 . Vaccine adjuvant systems containing monophosphoryl lipid a and qs21 induce strong and persistent humoral and t cell responses against hepatitis b surface antigen in
    . Vaccine , [2008]
  • Flublok , a next generation influenza vaccine manufactured in insect cells
    37 : 182-189 . [2009]
  • Flach TL, Ng G, Hari A, Desrosiers MD, Zhang P, Ward SM, Seamone ME, Vilaysane A, Mucsi AD, Fong Y, Prenner E, Ling CC, Tschopp J, Muruve DA, Amrein MW, Shi Y. 2011. Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity. Nat Med, 17: 479-487.
  • Facile one-pot electrosynthesis of al ( oh ) 3– kinetics and equilibrium modeling for adsorption of 2 , 4 , 5- trichlorophenoxyacetic acid from aqueous solution
    40 : 2249-2258 . [2016]
  • Evidence for phagocytosis of influenza virus-infected , apoptotic cells by neutrophils and macrophages in mice
    178 : 2448-2457 [2007]
  • Evasion of natural killer cells by influenza virus
    89 : 189-194 [2011]
  • Evasion of innate and adaptive immune responses by influenza a virus
    12 : 873-880 [2010]
  • Evaluation of a primary course of h9n2 vaccine with or without as03 adjuvant in adults : A phase i/ii randomized trial
    35 : 4621-4628 .
  • Evaluating the safety of new vaccines : Summary of a workshop
    95 : 800-807 [2005]
  • Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza a virus
    113 : 11931-11936 . [2016]
  • Enhancement of adaptive immunity by the human vaccine adjuvant as01 depends on activated dendritic cells
    193 : 1920-1930 [2014]
  • Enhanced immunogenicity of seasonal influenza vaccines in young children using mf59 adjuvant
    28 : 563-571 [2009]
  • Enhanced and persistent antibody response against homologous and heterologous strains elicited by a mf59® -adjuvanted influenza vaccine in infants and young children
    32 : 6146-6156
  • Emerging infections : Pandemic influenza
    18 : 64-76 . [1996]
  • Ekiert DC, Friesen RH, Bhabha G, Kwaks T, Jongeneelen M, Yu W, Ophorst C, Cox F, Korse HJ, Brandenburg B, Vogels R, Brakenhoff JP, Kompier R, Koldijk MH, Cornelissen LA, Poon LL, Peiris M, Koudstaal W, Wilson IA, Goudsmit J. 2011. A highly conserved neutralizing epitope on group 2 influenza a viruses. Science, 333: 843-850.
  • Efficacy of recombinant influenza vaccine in adults 50 years of age or older
    376 : 2427-2436 [2017]
  • Efficacy of live attenuated influenza vaccine in children : A metaanalysis of nine randomized clinical trials
    27 : 1101-1110 [2009]
  • Efficacy and effectiveness of influenza vaccines : A systematic review and metaanalysis
    12 : 36-44 . [2012]
  • Effectiveness of 2009 pandemic influenza a ( h1n1 ) vaccines : A systematic review and meta-analysis
    35 : 1996-2006 . [2017]
  • Effectiveness , immunogenicity , and safety of influenza vaccines with mf59 adjuvant in healthy people of different age groups : A systematic review and metaanalysis
    99 : e19095 [2020]
  • Effect of varying doses of a monovalent h7n9 influenza vaccine with and without as03 and mf59 adjuvants on immune response: A randomized clinical trial. JAMA, 314: 237-246.
  • Effect of aluminum hydroxide adjuvant on the immunogenicity of the 2009 pandemic influenza a/h1n1 vaccine : Multi-level modeling of data with repeated measures
    24 : 624-629 . [2011]
  • Early priming minimizes the age-related immune compromise of cd8 ( + ) t cell diversity and function
    8 : e1002544 . [2012]
  • Dose-range study of mf59-adjuvanted versus nonadjuvanted monovalent 158 a/h1n1 pandemic influenza vaccine in six-to less than thirty-six-month-old children .
    31 : e92-e98 . [2012]
  • Distinct effects of monophosphoryl lipid a , oligodeoxynucleotide cpg , and combination adjuvants on modulating innate and adaptive immune responses to influenza vaccination
    17 : 326-342 [2017]
  • Disregulated influenza a virus-specific cd8+ t cell homeostasis in the absence of ifngamma signaling
    178 : 7616-7622 . [2007]
  • Differentiation of effector cd4 t cell populations ( * )
    28 : 445-489 . [2010]
  • Development of the cpg adjuvant 1018 : A case study
    [2017]
  • Development and evaluation of as03 , an adjuvant system containing alpha-tocopherol and squalene in an oil-in-water emulsion
    11 : 349-366 . [2012]
  • Detection of influenza c virus but not influenza d virus in scottish respiratory samples
    74 : 50-53 [2016]
  • Dendritic cell activation by an e. Coli-derived monophosphoryl lipid a enhances the efficacy of pd-1 blockade .
    472 : 19-28 . [2020]
  • Dawood FS, Iuliano AD, Reed C, Meltzer MI, Shay DK, Cheng PY, Bandaranayake D, Breiman RF, Brooks WA, Buchy P, Feikin DR, Fowler KB, Gordon A, Hien NT, Horby P, Huang QS, Katz MA, Krishnan A, Lal R, Montgomery JM, Molbak K, Pebody R, Presanis AM, Razuri H, Steens A, Tinoco YO, Wallinga J, Yu H, Vong S, Bresee J, Widdowson MA.
  • Dauvilliers Y, Arnulf I, Lecendreux M, Monaca Charley C, Franco P, Drouot X, d'Ortho MP, Launois S, Lignot S, Bourgin P, Nogues B, Rey M, Bayard S, Scholz S, Lavault S, Tubert-Bitter P, Saussier C, Pariente A, Narcoflu VFsg. 2013. Increased risk of narcolepsy in children and adults after pandemic h1n1 vaccination in france. Brain, 136: 2486-2496.
  • Cytokine production associated with smallpox vaccine responses
    6 : 1097-1112 . [2014]
  • Current and future influenza vaccines
    25 : 212-220 . [2019]
  • Cumulative clinical experience with mf59-adjuvanted trivalent seasonal influenza vaccine in young children
    85S : S26-S38 [2019]
  • Cross-protective efficacies of highly-pathogenic avian influenza h5n1 vaccines against a recent h5n8 virus
    498 : 36-43 [2016]
  • Cpg-DNAmediated transient lymphadenopathy is associated with a state of th1 predisposition to antigen-driven responses
    165 : 1228-1235 . [2000]
  • Cpg oligonucleotides as adjuvants for vaccines targeting infectious diseases
    61 : 248-255 . [2009]
  • Cpg motifs in bacterial DNA and their immune effects
    20 : 709-760 . [2002]
  • Correlates of gla family adjuvants ' activities
    39 : 22-29 . [2018]
  • Control of influenza and poliomyelitis with killed virus vaccines
    195 : 834-847 [1977]
  • Contributions of humoral and cellular immunity to vaccine-induced protection in humans .
    411 : 206-215 [2011]
  • Complement and natural antibody are required in the long-term memory response to influenza virus
    26 Suppl 8 : I86-93 [2008]
  • Coagulation-adsorption of reactive orange from aqueous solution by freshly formed magnesium hydroxide : Mixing time and mechanistic study
    75 : 1776- 1783 [2017]
  • Clinical evaluation of cpg oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer
    32 : 6377-6389 [2014]
  • Clearance of influenza virus from the lung depends on migratory langerin+cd11b- but not plasmacytoid dendritic cells
    205 : 1621-1634 . [2008]
  • Chowell G. 2016Global mortality impact of the 1957-1959 influenza pandemic .
    213 : 738-745 .
  • Cell culture-based influenza vaccines : A necessary and indispensable investment for the future
    11 : 1223-1234 . [2015]
  • Cd4+ and cd8+ t cells exhibit differential requirements for ccr7-mediated antigen transport during influenza infection
    181 : 6984-6994 . [2008]
  • Ccr7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs
    99 : 23-33 . [1999]
  • Broadly neutralizing hemagglutinin stalk-specific antibodies require fcgammar interactions for protection against influenza virus in vivo
    20 : 143-151 . [2014]
  • Body temperature measurement in mice during acute illness : Implantable temperature transponder versus surface infrared thermometry
    2.781944444 [2018]
  • Blocking the cd40l-cd40 interaction in vivo specifically prevents the priming of t helper 1 cells through the inhibition of interleukin 12 secretion .
    183 : 693-698 . [1996]
  • Bioderived polyelectrolyte nanogels for robust antigen loading and vaccine adjuvant effects
    7 : 3281- 3286 . [2011]
  • Beyond empiricism : Informing vaccine development through innate immunity research
    148 : 1284-1292 [2012]
  • Beyond antigens and adjuvants : Formulating future vaccines
    126 : 799-808 [2016]
  • Bellamy AR
    [2015]
  • Bacterial cpg-DNA activates dendritic cells in vivo : T helper cell-independent cytotoxic t cell responses to soluble proteins
    30 : 3591- 3597 [2000]
  • Avian flu : Influenza virus receptors in the human airway .
    440 : 435-436 [2006]
  • As03-and mf59-adjuvanted influenza vaccines in children
    1.555555556
  • As03- adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people : A phase 3 randomised trial
    13 : 485-496 . [2013]
  • As03 adjuvanted ah1n1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in finland
    7 : e33536 . [2012]
  • As03 ( a ) -adjuvanted influenza a ( h1n1 ) 2009 vaccine for adults up to 85 years of age
    51 : 668-677 . [2010]
  • Antigen-specific human t lymphocyte clones : Induction , antigen specificity , and mhc restriction of influenza virus-immune clones
    128 : 233-238 . [1982]
  • Antibody-dependent-cellular-cytotoxicity-inducing antibodies significantly affect the post-exposure treatment of ebola virus infection
    7
  • Antibody-dependent-cellular-cytotoxicityinducing antibodies significantly affect the post-exposure treatment of ebola virus infection
    7 : 45552 .
  • Antibody-dependent cellular cytotoxicity is associated with control of pandemic h1n1 influenza virus infection of macaques
    87 : 5512-5522 .
  • Antibody-dependent cellular cytotoxicity against primary hiv-infected cd4+ t cells is directly associated with the magnitude of surface igg binding
    86 : 8672-8680
  • Antibody recognition of a highly conserved influenza virus epitope
    324 : 246-251 [2009]
  • An intranasal virus-like particle vaccine broadly protects mice from multiple subtypes of influenza a virus
    6 : e01044 [2015]
  • An indirect comparison meta-analysis of as03 and mf59 adjuvants in pandemic influenza a ( h1n1 ) pdm09 vaccines
    37 : 4246-4255 . [2019]
  • Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs
    82 : 4265-4274 . [2008]
  • Aluminum salts as an adjuvant for prepandemic influenza vaccines : A meta-analysis
    8 : 11460 . [2018]
  • Alum boosts th2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection .
    26 : 2350-2359 . [2008]
  • Age-related impaired type 1 t cell responses to influenza : Reduced activation ex vivo , decreased expansion in ctl culture in vitro , and blunted response to influenza vaccination in vivo in the elderly
    172 : 3437-3446 . [2004]
  • Age-associated crossreactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza a virus subtype h1n1
    208 : 1051-1061 .
  • Adjuvants : Classification , modus operandi , and licensing
    1459394 [2016]
  • Adjuvanted influenza vaccines
    8 : 59-66 . [2012]
  • Adjuvant system as03 containing alphatocopherol modulates innate immune response and leads to improved adaptive immunity
    29 : 2461-2473 . [2011]
  • Adjuvant system as01 : Helping to overcome the challenges of modern vaccines
    16 : 55-63 . [2017]
  • Activation of nk cells by adcc responses during early hiv infection
    24 : 171-175
  • Activation of dendritic cells and induction of cd4 ( + ) t cell differentiation by aluminum-containing adjuvants
    25 : 4575-4585 . [2007]
  • Activated t cells induce interleukin-12 production by monocytes via cd40-cd40 ligand interaction .
    25 : 1125- 1128 [1995]
  • Accelerated cd8+ t-cell memory and prime-boost response after dendriticcell vaccination
    11 : 748-756 . [2005]
  • A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among children
    34 : 714-722 . [2016]
  • A simple method for estimating fifty percent endpoint
    27 : 493-497 . [1938]
  • A novel transcription factor , t-bet , directs th1 lineage commitment
    100 : 655- 669 . [2000]
  • A history of influenza .
    91 : 572-579 . [2001]
  • 2012. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza a h1n1 virus circulation: A modelling study. Lancet Infect Dis, 12: 687-695.
  • , deCarvalho NS , Skinner SR , Harper DM , Hedrick JA , Jaisamrarn U , Limson GA , Dionne M , Quint W , Spiessens B , Peeters P , Struyf F
    , Lehtinen MO ,
  • , Wettendorff MA . 2006 . Enhanced humoral and memory bCellular immunity using hpv16/18 l1 vlp vaccine formulated with the mpl/aluminium saltCombination ( as04
    aluminium salt only . Vaccine
  • , Mahmud SM , VanCaeseele P , Li Y . 2014 . Low 2012-13 influenza vaccine effectiveness associated with
    h3n2 vaccine strain not
  • , Hanson BJ , Gascoigne NRJ , MacAry PA. 2017b . Tcr-like antibodies mediateComplement and antibody-dependentCellularCytotoxicity against epstein-barr virustransformed b lymphoblastoidCells expressing different
    . Sci Rep ,